ArticleThe Journal of clinical investigation2024

An inducible RIPK3-driven necroptotic system enhances cancer cell-based immunotherapy and ensures safety.

Kok-Siong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.